Drug Shortage Report for ATHENA-ONDANSETRON ODT
Report ID | 29122 |
Drug Identification Number | 02444682 |
Brand name | SANDOZ ONDANSETRON ODT |
Common or Proper name | ONDANSETRON |
Company Name | ATHENA PHARMACEUTIQUES SAS |
Market Status | DORMANT |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 8MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | BLISTERS 10'S |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-10-03 |
Estimated end date | 2017-11-20 |
Actual end date | 2017-11-15 |
Shortage status | Resolved |
Updated date | 2017-11-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ESPACE ARNOLD DE VILLE, 12 RUE GEORGES BLANDON LOUVECIENNES, -- FRANCE 78430 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-11-27 | French | Compare |
v3 | 2017-11-27 | English | Compare |
v2 | 2017-11-13 | French | Compare |
v1 | 2017-11-13 | English | Compare |
Showing 1 to 4 of 4